инхибитор (N=4603)%
Total population (intent- to- treat) Arm A Arm B B– A Arm C C– A UFH/ enox bival Risk bival Risk +GPIIb/ IIIa +GPIIb/ IIIa skillnad enbart skillnad hämmare hämmare (95% KI) (N=4612) (95% KI) (N=4603) (N=4604)%%% 30 dagar